Coeliac disease (CD) is an autoimmune disorder caused by the ingestion of gluten-containing grains. One of the prerequisites for the development of the disease is the presence of specific combinations of HLA alleles at the DQA1 and DQB1 loci. The HLA test is a supportive diagnostic test. In the Czech Republic, approximately 3,500 HLA tests for CD diagnosis are performed annually in almost three dozen laboratories. The HLA Department of the Institute of Haematology and Blood Transfusion in Prague has been offering the EPT "Detection of HLA Alleles Associated with Diseases" for more than 10 years. The results are evaluated in terms of the correct determination of predisposing alleles/allelic groups and clinical interpretation. Every year, we notice some problems with the detection of CD-associated alleles and the interpretation of results. Annual workshops are part of this EPT, and they also include recommendations for the interpretation of results. This interpretation is evolving based on the current knowledge in the field. The current recommendation for interpretation was adopted in 2023, dividing HLA-DQA1/DQB1 genotypes into three categories: 1) detected HLA genotype is associated with predisposition to coeliac disease; 2) coeliac disease could not be excluded based on the detected HLA genotype; 3) coeliac disease could be excluded with high probability based on the detected HLA genotype. The quality of examination is increasing but still needs improvement. Correct results and accurate interpretation can inform clinicians' decisions about the diagnosis of coeliac disease in appropriate patients.

Department of HLA Institute of Hematology and Blood Transfusion Prague Czechia

Department of Medical Genetics Thomayer University Hospital Prague Czechia

HLA laboratory Department of Immunology University Hospital Olomouc Czechia

Zobrazit více v PubMed

Al-Toma A., Volta U., Auricchio R., Castillejo G., Sanders D. S., Cellier C., et al. (2019). European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gluten-related disorders. United Eur. Gastroenterol. J. 7 (5), 583–613. Epub 2019 Apr 13. PMID: 31210940; PMCID: PMC6545713. 10.1177/2050640619844125 PubMed DOI PMC

Catassi C., Verdu E. F., Bai J. C., Lionetti E. (2022). Coeliac disease. Lancet. 399 (10344), 2413–2426. 10.1016/S0140-6736(22)00794-2 PubMed DOI

Devriese M., Rouquie J., Da Silva S., Benassaya N., Maillard L., Dewez M., et al. (2024). Single locus HLA sequencing with the nanopore technology for HLA disease association diagnosis. HLA 103, e15424. 10.1111/tan.15424 PubMed DOI

Elwenspoek M. M. C., Jackson J., O'Donnell R., Sinobas A., Dawson S., Everitt H., et al. (2021). The accuracy of diagnostic indicators for coeliac disease: a systematic review and meta-analysis. PLoS One 16 (10), e0258501. Published 2021 Oct 25. 10.1371/journal.pone.0258501 PubMed DOI PMC

Erlichster M., Bedo J., Skafidas E., Kwan P., Kowalczyk A., Goudey B. (2020). Improved HLA-based prediction of coeliac disease identifies two novel genetic interactions. Eur. J. Hum. Genet. 28 (12), 1743–1752. 10.1038/s41431-020-0700-2 PubMed DOI PMC

Evans D. A. (1973). Letter: coeliac disease and HL-A8. Lancet. 2 (7837), 1096. PubMed

Husby S., Koletzko S., Korponay-Szabó I., Kurppa K., Mearin M. L., Ribes-Koninckx C., et al. (2020). European society paediatric Gastroenterology, Hepatology and nutrition guidelines for diagnosing coeliac disease 2020. J. Pediatr. Gastroenterol. Nutr. 70 (1), 141–156. 10.1097/MPG.0000000000002497 PubMed DOI

Husby S., Koletzko S., Korponay-Szabó I. R., Mearin M. L., Phillips A., Shamir R., et al. (2012). European society for pediatric Gastroenterology, Hepatology, and nutrition guidelines for the diagnosis of coeliac disease. J. Ped Gastroenterology& Nutr. 54, 136–160. 10.1097/MPG.0b013e31821a23d0 PubMed DOI

Levescot A., Malamut G., Cerf-Bensussan N. (2022). Immunopathogenesis and environmental triggers in coeliac disease. Gut 71 (11), 2337–2349. 10.1136/gutjnl-2021-326257 PubMed DOI PMC

Maimaris S., Schiepatti A., Scarcella C., Badulli C., Biagi F. (2024). HLA-DQ7.5 and coeliac disease. Int. J. Immunogenet 51 (3), 192–193. 10.1111/iji.12671 PubMed DOI

Megiorni F., Pizzuti A. (2012). HLA-DQA1 and HLA-DQB1 in Celiac disease predisposition: practical implications of the HLA molecular typing. J. Biomed. Sci. 19 (1), 88. Published 2012 Oct 11. 10.1186/1423-0127-19-88 PubMed DOI PMC

Mrazek F. (2023). Population genetics and external proficiency testing for HLA disease associations. Front. Genet. 14, 1268705. Published 2023 Oct 23. 10.3389/fgene.2023.1268705 PubMed DOI PMC

Pritchard D., Anand A., De'Ath A., Lee H., Rees M. T. (2024). UK NEQAS and BSHI guideline: laboratory testing and clinical interpretation of HLA genotyping results supporting the diagnosis of coeliac disease. Int. J. Immunogenet 51, 3–20. 10.1111/iji.12649 PubMed DOI

Sollid L. M. (2024). Tolerance-inducing therapies in coeliac disease - mechanisms, progress and future directions. Nat. Rev. Gastroenterol. Hepatol. 21 (5), 335–347. 10.1038/s41575-024-00895-3 PubMed DOI

Tye-Din J. A., Cameron D. J., Daveson A. J., Day A. S., Dellsperger P., Hogan C., et al. (2015). Appropriate clinical use of human leukocyte antigen typing for coeliac disease: an Australasian perspective. Intern Med. J. 45 (4), 441–450. 10.1111/imj.12716 PubMed DOI PMC

Vraná M., Kelifová S., Ratajová E., Szitanyi P. (2017). Genetické vyšetření HLA pro diagnostiku celiakie. Postgr. Gastroenterol. a Hepatol. 3, 2. ISSN 2336-4998.

Zajacova M., Kotrbova-Kozak A., Cerna M. (2016). HLA-DRB1, -DQA1 and -DQB1 genotyping of 180 Czech individuals from the Czech Republic pop 3. Hum. Immunol. 77 (4), 365–366. Epub 2016 Feb 8. 10.1016/j.humimm.2016.02.003 PubMed DOI